Give Your Brain the Signal It's Begging For
Tinnitus is your brain desperately searching for a lost signal. NeuroMonics is a structured neurological desensitization protocol that gives that signal back, calming your nervous system and retraining your brain to reduce its response to phantom sound. FDA-cleared. Clinician-guided. Backed by 20 years of published research.
Free Tinnitus Assessment →all published trials
clinical trials
Australian medical centers
Veterans Affairs
Your brain is not broken. It is doing exactly what it was designed to do with bad information.
Understanding why tinnitus happens is the first step to understanding why NeuroMonics works.
Why tinnitus persists, and how we treat it
Tinnitus is a neurological condition, not an ear condition. These four principles explain why the brain generates phantom sound and why the NeuroMonics protocol can systematically address it through neurological desensitization.
Your Brain's "Code for Silence"
A healthy auditory nerve fires about one million random impulses per second, even in complete silence. Your brain interprets this steady stream as silence. When hearing damage reduces that stream, the brain compensates by turning up its own internal sensitivity. It detects the resulting neural hyperactivity and misinterprets it as sound. That is tinnitus.
NeuroMonics restores the missing input by delivering a customized broadband neural stimulus matched to your individual hearing profile.
Heart-Rate Synchronization
Tinnitus triggers your limbic system and autonomic nervous system, locking your body into a fight-or-flight stress response. The NeuroMonics acoustic stimulus uses music specifically structured to mirror a relaxed resting heart rate. Because the music bypasses linguistic processing, it reaches the limbic system directly, actively inducing calm rather than masking the problem.
This is a targeted physiological intervention, not relaxation music.
Binaural Processing
Hearing loss is typically asymmetrical. Standard audio becomes painfully loud in your stronger ear before it reaches the tinnitus in your weaker ear. NeuroMonics compensates for this asymmetry by calibrating separately for each ear, creating a balanced stimulus that addresses tinnitus perceived deep inside the head, not just in one ear.
This is why one-size-fits-all sound apps and playlists do not produce clinical results.
Overcoming Frequency Limitations
Standard hearing aids and tabletop sound generators are limited by physics: high-frequency sounds lose energy quickly traveling through open air. They struggle to deliver meaningful stimulation above 4,000 Hz without uncomfortable volume levels. Because NeuroMonics uses earphones, it delivers a true broad-frequency stimulus directly to the auditory pathways that need it most.
Earphone delivery circumvents the physical limitations that constrain hearing aids and maskers.
Three brain systems working against you
These three pathways amplify and reinforce each other. Treatments that target only one pathway fail because the other two keep the cycle running. NeuroMonics addresses all three simultaneously.
The self-reinforcing tinnitus cycle
Each system amplifies the others. Single-pathway treatments fail.
Auditory Perception
The brain compensates for reduced input by increasing internal sensitivity. It detects its own neural hyperactivity and misinterprets it as sound.
The brain amplifies a signal that is not there.
Emotional Response
The limbic and autonomic nervous systems treat the unfamiliar signal as a threat, activating fight-or-flight. This generates anxiety, hypervigilance, and emotional distress.
Distress makes tinnitus feel louder and more intrusive.
Attention & Awareness
Once flagged as significant, the brain's attentional filters lock onto tinnitus, keeping it at the forefront of consciousness instead of filtering it as background noise.
Attention reinforces the neural pathways, deepening the cycle.
Three pathways. One integrated treatment.
The NeuroMonics protocol is a structured neurological desensitization program delivered through a clinician-guided 26-week treatment cycle. Each component addresses a specific neural pathway. Together, they produce neuroplastic changes in how the brain processes the tinnitus signal.
Published long-term follow-up studies demonstrate sustained benefits at 12 to 36 months post-treatment. The changes are structural, not temporary.
How we define and measure success
All NeuroMonics trials measure outcomes using the Tinnitus Reaction Questionnaire (TRQ), a validated 26-item psychometric instrument. Scores range from 0 to 104.
A 40% or greater reduction in TRQ score is the established criterion for clinically significant improvement. The 83% efficacy figure reflects the proportion of patients who crossed this threshold.
Neurological desensitization is measured when patients sustain improvement beyond the active treatment period.
Consistent results across independent settings
The majority of NeuroMonics studies were conducted by independent researchers across Veterans Affairs facilities, university medical centers, and private practice.
| Study | Subjects | Location | Study Type | Efficacy* |
|---|---|---|---|---|
| Hollywood VA | 35 | Veterans Affairs, United States | Independent | 96% |
| Private Practice | 470 | Australia | NeuroMonics | 92% |
| Trial 3 | 35 | Australia | NeuroMonics | 90% |
| Tavori TRI | 25 | Australia | Independent | 90% |
| Trial 2 | 50 | Australia | NeuroMonics | 86% |
| CALM — Cleveland Clinic | 51 | United States | Independent | 81% |
| Lions Ear Institute | 29 | Australia | Independent | 75% |
| Tavora AAA | 70 | US / Australia | Independent | 75% |
| Australian Veterans | 50 | Veterans Affairs, Australia | Independent | 74% |
| Oregon Tinnitus Clinic | 24 | United States | Independent | 72% |
| Total / Average | 1,033 | — | — | 83% |
* Success defined as 40% or greater reduction in Tinnitus Reaction Questionnaire score. Table represents 10 of 14 total published peer-reviewed studies.
Read the science
Published in peer-reviewed journals across audiology, otolaryngology, and tinnitus research.
Give your brain the signal it needs
Discover whether you are a candidate for the NeuroMonics neurological desensitization protocol. Free to assess. No clinic visit required.
